undamentalytics Newsletter

Bentsur Ron: insider trades

Chief executive, Director at 2 companies we cover. 26 open-market purchases and 4 sales not made under a pre-set plan, reported from February 8, 2021 to July 1, 2026.

Would copying Bentsur Ron’s purchases have beaten the S&P 500?

Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on February 16, 2022 into $32,920 by November 2, 2026, +28.9% a year. The copy held shares only 100% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $18,047, +13.4% a year (the S&P 500 held throughout made $18,047, +13.4% a year). Beta against the index was 0.48. Twelve months after each report, the average purchase was +13.0% against the S&P 500 (median +21.2%), and 71% beat it: too few years of purchases to tell skill from luck. Measured from the trade date, the insider’s own timing, the average was +6.6%. After their sales, the shares moved −33.4% against the index over 12 months on average (a negative figure means selling was the right call); 75% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 20222023202420252026 $32.9k$18.0k$18.0k
Copying Bentsur RonS&P 500, same days investedS&P 500, held throughout $10,000 copying Bentsur Ron’s open-market purchases from February 16, 2022, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+28.9%
S&P 500, same days invested
+13.4% (held throughout +13.4%)
Time in shares
100%
Sharpe ratio (S&P 500)
0.68 (0.57)
Biggest drop (S&P 500)
−79% (−22%)
Market sensitivity (beta)
0.48
Purchases copied
26

Trade by trade

Bentsur Ron: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 26 +7.3% −12.8% 31% 5 1.53 0.20 No reliable evidence
Purchases, 6 months after the report 25 −2.6% +6.8% 52% 4 0.47 0.67 No reliable evidence
Purchases, 12 months after the report 24 +13.0% +21.2% 71% 3 — — Not enough years
Purchases, 12 months after the trade 22 +6.6% +10.7% 55% 3 — — Not enough years
Sales, 3 months after the report 4 −31.4% −32.8% 100% 2 — — Not enough years
Sales, 12 months after the report 4 −33.4% −30.4% 75% 2 — — Not enough years
Sales, 12 months after the trade 4 −13.6% −22.8% 75% 3 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Nuvectis Pharma, Inc. NVCT Chairman & CEO250February 15, 2022July 1, 2026
Beyond Air, Inc. XAIR —14February 8, 2021March 21, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
July 1, 2026June 30, 2026 NVCT Purchase $250,000 +3.0%not yetnot yet
November 6, 2025November 5, 2025 NVCT Purchase $28,600 +38.9%not yetnot yet
December 26, 2024December 24, 2024 NVCT Purchase $20,925 +84.6%+28.7%not yet
November 18, 2024November 15, 2024 NVCT Purchase $98,400 +41.7%+5.3%not yet
May 15, 2024May 14, 2024 NVCT Purchase $13,076 −9.0%+49.5%+30.8%
May 13, 2024May 10, 2024 NVCT Purchase $12,800 −10.3%+30.8%+30.1%
March 19, 2024March 18, 2024 NVCT Purchase $51,450 −27.0%+0.4%−21.9%
October 10, 2023October 6, 2023 NVCT Purchase $12,105 −15.0%−72.4%−81.9%
October 6, 2023October 4, 2023 NVCT Purchase $35,455 −16.5%−79.6%−81.3%
June 27, 2023June 26, 2023 NVCT Purchase $12,375 −12.7%−88.0%−88.7%
March 21, 2023March 20, 2023 XAIR Purchase $14,904 −26.3%−111.2%−110.2%
March 16, 2023March 14, 2023 NVCT Purchase $23,465 +38.4%−60.8%−45.0%
September 27, 2022September 23, 2022 NVCT Purchase $11,775 −0.4%+59.6%+56.3%
September 6, 2022September 1, 2022 NVCT Purchase $14,099 −9.1%+51.5%+58.6%
August 30, 2022August 23, 2022 NVCT Purchase $13,570 −12.8%+66.7%+58.8%
August 22, 2022August 18, 2022 NVCT Purchase $168,725 −15.3%+58.8%+65.4%
August 16, 2022August 11, 2022 NVCT Purchase $165,220 −18.1%+61.7%+66.7%
July 5, 2022June 30, 2022 XAIR Sale $261,200 −19.8%−75.4%−59.2%
June 30, 2022June 28, 2022 NVCT Purchase $46,540 −34.9%+13.6%+18.0%
May 31, 2022May 26, 2022 NVCT Purchase $15,820 −33.2%+32.1%+3.5%
May 23, 2022May 19, 2022 NVCT Purchase $20,070 −50.0%+0.8%−15.7%
May 19, 2022May 17, 2022 NVCT Purchase $39,155 −48.8%+1.6%−22.0%
May 17, 2022May 13, 2022 NVCT Purchase $31,990 −63.1%−18.6%−14.2%
May 13, 2022May 12, 2022 NVCT Purchase $208,047 −59.6%−16.1%−12.0%
March 29, 2022March 28, 2022 NVCT Purchase $28,200 +78.3%+97.6%+82.0%
March 18, 2022March 17, 2022 NVCT Purchase $53,410 +117.9%+113.8%+72.1%
February 15, 2022February 14, 2022 NVCT Purchase $47,040 +250.6%+86.3%+95.5%
November 26, 2021November 24, 2021 XAIR Sale $507,071 −40.3%−46.9%−44.2%
February 18, 2021February 11, 2021 XAIR Sale $158,365 −30.6%+2.8%−1.4%
February 8, 2021January 2, 2021 XAIR Sale $33,573 −34.9%−13.9%+50.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Bentsur Ron traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.